In previous studies (2-4), a unique hemagglutinin inhibitor was described. It occurs in crude tumorous ascitic plasma and acts on vaccinia virus to produce a stable hemagglutinin-negative virus. It was determined that it is a nondialyzable protein, unstable at acidic pH, and thermolabile above 50 C. It was also established that the inhibitor will not neutralize the infectivity of vaccinia virus and is not an antibody. Available evidence suggests that the inhibitor is related to nontumorous cell components of ascites tumors.
Further studies indicate that it may act by forming a complex with a hemagglutinin template necessary for the formation of more hemagglutinin (7) .
The hemagglutinin-negative virus produced was found to be the most suitable strain of vaccinia virus for immunizing mouse colonies against mousepox and had the advantage of not stimulating hemagglutinin-inhibiting antibodies, which otherwise would complicate the detection of such antibodies in mice subsequently exposed to mousepox (1) .
Since all previous studies of this inhibitor were carried out with crude ascitic plasma, it remained uncertain that the activity could withstand separation from the whole plasma. The present study, therefore, was undertaken to attempt the separation of inhibitor activity from the crude plasma, so that further evidence for a specific role of the inhibitor in the alteration of vaccinia virus could be obtained.
MATERIALS AND METHODS
Ascitic plasma. The Lettre, hyperdiploid line of the Ehrlich ascites tumor was carried in NIH mice. After the inoculation of 4 X 107 tumor cells, mice were held for 2 weeks before the tumor was aspirated and the plasma was harvested by low-speed centrifugation.
Assay of inhibitor. The assay is described in detail ' Publication 1035 of the Division of Basic Health Sciences, Emory University. in a previous report (7) . Twofold serial dilutions of inhibitor were each reacted with 2 Molecular weight estimation. The molecular weight was estimated by the method of Martin and Ames (6) , with the use of a 5 to 20%c sucrose gradient. The "'marker" was normal human hemoglobin.
Virus. Hemagglutinin-positive vaccinia virus strain IHD-E was employed and was assayed on primary monkey kidney cells (7) . L cells. Uncloned L cells were cultured routinely in medium 199, containing 20%c calf serum, and were carried in plastic flasks (Falcon no. 3012) containing 5 ml of medium.
Monkey kidney cells and hemadsorption. The procedures were exactly as described in an earlier report (7) . Primary cultures of rhesus monkey kidney cells were inoculated with virus and incubated for 4 days, with an agar overlay. The agar was then removed, and the cell layer was exposed to chicken erythrocytes. After 20 min, the loose erythrocytes were washed off, and the hemadsorption status of the viral plaques was determined.
RESULTS
Partial purification of the inhibitor. Of various procedures employed in an effort to concentrate and purify the inhibitor, the following combination proved to be the best. The inhibitor was precipitated by adding ammonium sulfate to ascitic plasma at 4 C to produce a 1.4 M concentration. After removal by centrifugation, the precipitate was dissolved in 0.3 M NaCl (10 ml) equal to one- Table 1 . Gel analysis of partially purified inhibitor. Figure 1 compares the polyacrylamide gel electrophoresis of purified inhibitor and whole ascitic plasma. It is evident that a vast amount of protein has been removed from the separated inhibitor and that a single band remains. Efforts to extract and identify inhibitor from the band failed.
Molecular weight of the inhibitor. One of the unsuccessful attempts at purification of the inhibitor involved the use of molecular sieves. Preparatory to the selection of a suitable sieve, the molecular weight of the inhibitor was estimated and is of particular interest in itself. From the data in Fig. 2 and the mathematical procedure of Martin and Ames (6), the molecular weight was estimated to be 209,000.
Biological activity of the partially purified inhibitor. Because purified inhibitor was to be introduced into a cell culture system, sterile reagents and equipment were used in its preparation. The particular lot of inhibitor used in this study showed a 16.5-fold increase in specific activity over the original plasma, gave a single band on gel electrophoresis, and had an HI titer of 16,384. DISCUSSION There is evidence that the inhibitor does not lend itself readily to isolation as a definable, homogeneous entity. Possibly, it may be split into subunits by certain laboratory procedures. Heterogeneity is suggested by the plateau from the sucrose gradient data in Fig. 1 and by the fact that on passage through molecular sieves the HI activity of the inhibitor spreads out over many tubes. Total original HI activity could not be obtained by recombining these fractions. Also suggesting heterogeneity is the behavior of the inhibitor upon heating. When it is held at 70 C, there is a sharp drop in HI activity. In 10 min, a plateau is reached and maintained for 1 hr, followed by a second decline in activity.
Various other attempts to purify the inhibitor were essentially ineffective. These included a wide range of methods: precipitation by alcohol, by perchloric acid, or at the isoelectric point, and column separation by diethylaminoethyl, carboxymethyl cellulose, and molecular sieves (Sephadex, Sepharose). The presently reported procedure at least indicates that activity can be preserved after a significant amount of impurities is removed. The fact that it was not possible to relate HI activity to the single band obtained on gel electrophoresis may reflect the relative insensitivity of the HI test, which is the only method for inhibitor detection. Although low in yield, the product obtained exhibited the established inhibitor properties. This indicated that the separation procedure in no way modified the action of the inhibitor on the hemagglutinin of vaccinia virus, thus providing supportive evidence for a specific role of the inhibitor in the alteration of the virus.
